7145 related articles for article (PubMed ID: 16004800)
21. Anti-cell death activity promotes pulmonary metastasis of melanoma cells.
Takaoka A; Adachi M; Okuda H; Sato S; Yawata A; Hinoda Y; Takayama S; Reed JC; Imai K
Oncogene; 1997 Jun; 14(24):2971-7. PubMed ID: 9205104
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
24. Expression of co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity.
Xiang J
Cancer Biother Radiopharm; 1999 Oct; 14(5):353-61. PubMed ID: 10850320
[TBL] [Abstract][Full Text] [Related]
25. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
26. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
Tan XH; Liu C; Wan YH
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):658-61. PubMed ID: 17274369
[TBL] [Abstract][Full Text] [Related]
27. [Establishment of mouse melanoma B16 cell lines co-expressing MAGE-1 and EGFP].
Chen GS; Ye J; Song HP; Zhang XM; Huang YY; Ma JH; Sui YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):212-4. PubMed ID: 15191728
[TBL] [Abstract][Full Text] [Related]
28. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
29. [Effects of STAT3 antisense oligodeoxynucleotides on apoptosis and proliferation of mouse melanoma cell line B16].
Tang GS; Cai JM; Ni J; Xiang YS; Cui JG; Zhu D; Dong JR
Ai Zheng; 2006 Mar; 25(3):269-74. PubMed ID: 16536977
[TBL] [Abstract][Full Text] [Related]
30. [Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro].
Liu DY; Zheng HQ; Luo GQ
Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):957-61. PubMed ID: 15620188
[TBL] [Abstract][Full Text] [Related]
31. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
[TBL] [Abstract][Full Text] [Related]
32. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
33. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
34. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
[TBL] [Abstract][Full Text] [Related]
35. [Soluble PD-1 can augment anti-tumor immunity induced by HSP70-peptide complex in tumor-bearing mice].
Wang XH; Zhang GM; He YF; Zhang H; Feng ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):655-8. PubMed ID: 15555427
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma.
Kobayashi M; Fujita K; Katakura T; Utsunomiya T; Pollard RB; Suzuki F
Anticancer Res; 2002; 22(6C):4053-8. PubMed ID: 12553032
[TBL] [Abstract][Full Text] [Related]
37. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells.
Stoitzner P; Green LK; Jung JY; Price KM; Atarea H; Kivell B; Ronchese F
Cancer Immunol Immunother; 2008 Nov; 57(11):1665-73. PubMed ID: 18311487
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma.
Watanabe MA; Almeida DO; Serrano SV; Sales VS; Soares FA; de Lucca FL
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):393-8. PubMed ID: 9193794
[TBL] [Abstract][Full Text] [Related]
39. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
